Newron Pharmaceuticals S.p.A. | Cash Flow
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,493.10
13,020.30
26,675.80
16,569.10
5,885.10
17,340.60
Depreciation, Depletion & Amortization
48.00
40.10
75.80
36.00
53.30
54.30
Other Funds
2,284.30
5,110.80
10,123.40
4,851.70
2,254.80
3,304.40
Funds from Operations
7,160.70
7,869.50
16,476.60
21,384.90
8,086.60
20,590.70
Changes in Working Capital
5,990.30
4,139.40
2,874.40
159.10
1,111.30
2,080.50
Net Operating Cash Flow
13,151.00
12,008.90
13,602.20
21,225.80
9,197.90
18,510.20
Capital Expenditures
93.50
26.70
68.30
78.50
68.80
Sale of Fixed Assets & Businesses
370.50
-
-
-
-
Purchase/Sale of Investments
-
8,434.10
2,163.30
1,525.70
305.30
Net Investing Cash Flow
276.90
8,460.90
2,094.90
1,447.20
374.10
Issuance/Reduction of Debt, Net
439.40
435.90
384.40
394.50
404.10
Net Financing Cash Flow
439.40
20,870.40
29,931.40
27,338.40
24,379.60
Net Change in Cash
13,313.50
400.70
18,424.20
7,559.90
14,807.60
Free Cash Flow
13,219.90
12,028.30
13,666.20
21,301.00
9,224.50
Change in Capital Stock
-
21,306.30
30,315.80
27,732.90
24,783.70
About Newron Pharmaceuticals
View Profile
